Ratiopharm

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
ratiopharm
Private
IndustryPharmaceutical industry
Founded1974
FoundersMerckle family
HeadquartersUlm, Germany
Key people
Adolf Merckle, founder
Oliver Windholz, CEO
ProductsPharmaceuticals and generic medication.
RevenueIncrease 1.8 billion (2007)
Number of employees
5,417 (2007)
ParentTeva Pharmaceutical Industries
WebsiteRatiopharm.com
12-08-18-tilidin-retard.jpg

Ratiopharm is a German pharmaceutical company that is Europe's leading generics brand.

Ratiopharm was owned by Adolf Merckle and makes generic pharmaceuticals. They are based in Ulm, Germany, and products being distributed[clarification needed] in over 35 countries worldwide.

On March 18, 2010, Teva announced that it planned to acquire Ratiopharm for US$5 billion.[1][2] On August 10, 2010, Teva announced that it had completed its acquisition of Ratiopharm.[3]

See also[edit]

References[edit]

  1. ^ NATASHA SINGER (March 18, 2010). "Teva to Acquire Top German Generics Maker for $5 Billion". The New York Times. Retrieved March 18, 2010.
  2. ^ Teva to Acquire Generics Firm The Wall Street Journal March 19, 2010
  3. ^ "Teva Completes Acquisition of Ratiopharm". August 10, 2010. Archived from the original on August 18, 2010. Retrieved August 20, 2010.

External links[edit]